Virogin Biotech is based in Vancouver, Canada. It has raised $281M in total funding. Latest round: Series D.
Virogin Biotech is based in Vancouver, Canada. Virogin Biotech has raised $281M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in September 2021. The round record for Virogin Biotech runs through 2021; nothing later has been disclosed. Investors on record include Korea Investment Holdings, GF Securities, SDIC, Shenzhen Capital Group, CMG-SDIC Capital, CDH Investments and 5 others. 11 distinct backers are named across the disclosed rounds.
Round data for Virogin Biotech is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Vancouver and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026